Search results

Order by most recent / most popular / relevance

Results: 1-5 of 5

Data protection in Canada: too much? Too little?

Gowling Lafleur Henderson LLP
-
Canada
-
June 28 2011

Prior to the enactment in 2006 of the amendments to section C.08.004.1 of the Food and Drugs Regulations (Data Protection Regulations), Canada did not have an effective regime of data protection exclusivity

First PMPRB decision dismissing allegations of excessive pricing

Gowling Lafleur Henderson LLP
-
Canada
-
April 20 2010

The Patented Medicine Prices Review Board ("PMPRB") recently released its decision in the matter of Hoechst Marion Roussel Canada Inc. and the medicine NIOCODERM, a nicotine patch which assists those who are attempting to quit smoking; it is to be publicly posted on the PMPRB website today

PMPRB issues first vaccines pricing decision

Gowling Lafleur Henderson LLP
-
Canada
-
February 4 2010

In a decision dated December 21, 2009 (and published on the PMRPB website on January 28, 2010) the Patented Medicine Prices Review Board ("PMPRB") decided the merits of the matter of Sanofi Pasteur Limited and the medicines Quadracel and Pentacel, which are multi-component vaccines designed to protect against multiple diseases

Court overturns PMPRB's decisions in respect of the medicine copaxone

Gowling Lafleur Henderson LLP
-
Canada
-
November 18 2009

On November 12, 2009, Justice Hughes of the Federal Court allowed two judicial review applications of Teva Neuroscience G.P.-S.E.N.C. in respect of two decisions made by the Patented Medicine Prices Review Board

PMPRB releases revised compendium of policies, guidelines and procedures

Gowling Lafleur Henderson LLP
-
Canada
-
June 12 2009

On June 9, 2009, the Patented Medicine Prices Review Board (PMPRB), Canada's federal price control body, released its final revised Compendium of Policies, Guidelines and Procedures, containing the new Excessive Price Guidelines

Search results

Data protection in Canada: too much? Too little?

First PMPRB decision dismissing allegations of excessive pricing

PMPRB issues first vaccines pricing decision

Court overturns PMPRB's decisions in respect of the medicine copaxone

PMPRB releases revised compendium of policies, guidelines and procedures

Current Search

Suggested Facets

Workarea